Valuation: DVx Inc.

Market Cap 11.86B 72.44M 63.68M 59.28M 54.44M 102M 6.95B 104M 705M 275M 3.43B 272M 266M P/E 2024
61.4x
P/E 2025 23.9x
Enterprise Value 6.81B 41.61M 36.58M 34.05M 31.27M 58.71M 3.99B 59.49M 405M 158M 1.97B 156M 153M EV / Sales 2024
0.05x
EV / Sales 2025 0.08x
Free-Float
27.8%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
President 49 2026-06-25
Director of Finance/CFO 52 2024-05-31
Corporate Officer/Principal 57 -
Director TitleAgeSince
Chairman 61 2026-06-25
Director/Board Member 52 2026-06-25
Director/Board Member 65 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.32% - - 60.89M
-1.01%-1.84%+18.40%+6.49% 9.64B
+0.32%+6.07%+19.50%+10.70% 1.41B
+5.82%-7.32% - - 1.32B
+0.36%+1.81%+6.17%-9.32% 1.1B
+6.58%+4.65%+43.09%+24.82% 609M
+3.07%-3.23%-25.88%-53.26% 579M
-0.28%-0.70%-11.94%-11.04% 412M
+0.64%-9.75%+88.82%+129.98% 371M
+2.55%-3.01%-59.14%-82.45% 247M
Average +1.80%-1.38%+9.88%+1.99% 1.57B
Weighted average by Cap. +0.34%-1.52%+16.46%+5.23%

Financials

2024 2025
Net sales 45.85B 280M 246M 229M 211M 395M 26.87B 401M 2.72B 1.06B 13.27B 1.05B 1.03B 50.32B 307M 270M 252M 231M 434M 29.48B 440M 2.99B 1.17B 14.56B 1.15B 1.13B
Net income 172M 1.05M 924K 860K 790K 1.48M 101M 1.5M 10.22M 3.99M 49.76M 3.94M 3.86M 410M 2.51M 2.2M 2.05M 1.88M 3.54M 240M 3.58M 24.37M 9.52M 119M 9.4M 9.2M
Net Debt -7.48B -45.68M -40.16M -37.38M -34.33M -64.47M -4.38B -65.32M -444M -174M -2.16B -171M -168M -5.05B -30.83M -27.1M -25.23M -23.17M -43.51M -2.96B -44.08M -300M -117M -1.46B -116M -113M
Logo DVx Inc.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
Employees
334
Date Price Change Volume
26-07-28 JP¥949.00 0.00% 600
26-07-27 JP¥949.00 -0.11% 1,700
26-07-24 JP¥950.00 +0.11% 4,800
26-07-23 JP¥949.00 -1.04% 1,900
26-07-22 JP¥959.00 +0.84% 1,700

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3079 Stock